Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page
- Check5 days agoChange DetectedA new Study Status entry was added to the record history (noted on 2026-07-02 with 120 items) and an older entry dated 2026-06-05 was removed. This updates the visible history of the trial’s status and its historical record.SummaryDifference0.1%

- Check12 days agoChange DetectedThe record history now shows the page revision updated to v3.6.3, replacing the previous v3.6.2, reflecting an underlying platform update rather than changes to study content.SummaryDifference0.0%

- Check19 days agoChange DetectedFooter now displays Revision: v3.6.2, replacing v3.6.0. This indicates a recent software update applied to the page.SummaryDifference0.0%

- Check34 days agoChange DetectedOne addition indicates the study is no longer looking for participants, signaling that recruitment has ceased. The record history also shows a new revision tag v3.6.0 and the removal of the previous v3.5.5 revision, reflecting an update to the study documentation.SummaryDifference0.1%

- Check41 days agoChange DetectedThe history now includes a new revision tag, v3.5.5, indicating a minor site update. It replaces the previous v3.5.4 revision.SummaryDifference0.0%

- Check62 days agoChange DetectedA new revision entry v3.5.4 appears on 2026-05-08 with the Study Status item and the marker 118, while the previous revision v3.5.3 (2026-04-13) is removed from the history.SummaryDifference0.2%

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.